Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma.
Saved in:
| Title: | Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma. |
|---|---|
| Authors: | Yan Z; Department of Pathology, Duke University School of Medicine, Durham, NC.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC., Han Z; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC., Wang Y; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC., Beus M; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC., Zhang Y; Department of Hematology and Medical Oncology, Emory School of Medicine and the Winship Cancer Institute, Emory University, Atlanta, GA., Picado A; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC., Wells CI; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC., Wu J; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Weidenhammer LB; Department of Pathology, Duke University School of Medicine, Durham, NC., Pires KM; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, The University of Utah, Salt Lake City, UT., Leibold EA; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, The University of Utah, Salt Lake City, UT., Liu L; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC., Gooden DM; Small Molecule Synthesis Facility, Department of Chemistry, Duke University, Durham, NC., Spasojevic I; Pharmacokinetics and Pharmacodynamics Core, Duke Cancer Institute, and Department of Medicine, Duke University Medical Center, Durham, NC., Soderblom EJ; Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Durham, NC., Kang Y; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC., Boise LH; Department of Hematology and Medical Oncology, Emory School of Medicine and the Winship Cancer Institute, Emory University, Atlanta, GA., Willson TM; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC., Nikiforov MA; Department of Pathology, Duke University School of Medicine, Durham, NC.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC. |
| Source: | Blood [Blood] 2026 Jan 01; Vol. 147 (1), pp. 48-60. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40953235 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yan+Z%22">Yan Z</searchLink>; Department of Pathology, Duke University School of Medicine, Durham, NC.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Han+Z%22">Han Z</searchLink>; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Beus+M%22">Beus M</searchLink>; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Department of Hematology and Medical Oncology, Emory School of Medicine and the Winship Cancer Institute, Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Picado+A%22">Picado A</searchLink>; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Wells+CI%22">Wells CI</searchLink>; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Weidenhammer+LB%22">Weidenhammer LB</searchLink>; Department of Pathology, Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Pires+KM%22">Pires KM</searchLink>; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, The University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Leibold+EA%22">Leibold EA</searchLink>; Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, The University of Utah, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC.<br /><searchLink fieldCode="AU" term="%22Gooden+DM%22">Gooden DM</searchLink>; Small Molecule Synthesis Facility, Department of Chemistry, Duke University, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Spasojevic+I%22">Spasojevic I</searchLink>; Pharmacokinetics and Pharmacodynamics Core, Duke Cancer Institute, and Department of Medicine, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Soderblom+EJ%22">Soderblom EJ</searchLink>; Proteomics and Metabolomics Core Facility, Duke University School of Medicine, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Kang+Y%22">Kang Y</searchLink>; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Boise+LH%22">Boise LH</searchLink>; Department of Hematology and Medical Oncology, Emory School of Medicine and the Winship Cancer Institute, Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Willson+TM%22">Willson TM</searchLink>; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC.<br /><searchLink fieldCode="AU" term="%22Nikiforov+MA%22">Nikiforov MA</searchLink>; Department of Pathology, Duke University School of Medicine, Durham, NC.; Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, NC. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Jan 01; Vol. 147 (1), pp. 48-60. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40953235 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2025029950 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 48 Titles: – TitleFull: Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yan Z – PersonEntity: Name: NameFull: Han Z – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Beus M – PersonEntity: Name: NameFull: Zhang Y – PersonEntity: Name: NameFull: Picado A – PersonEntity: Name: NameFull: Wells CI – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Weidenhammer LB – PersonEntity: Name: NameFull: Pires KM – PersonEntity: Name: NameFull: Leibold EA – PersonEntity: Name: NameFull: Liu L – PersonEntity: Name: NameFull: Gooden DM – PersonEntity: Name: NameFull: Spasojevic I – PersonEntity: Name: NameFull: Soderblom EJ – PersonEntity: Name: NameFull: Kang Y – PersonEntity: Name: NameFull: Boise LH – PersonEntity: Name: NameFull: Willson TM – PersonEntity: Name: NameFull: Nikiforov MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 147 – Type: issue Value: 1 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |